A Prospective, Single-center, Open-label Clinical Study to Evaluate the Safety and Efficacy of Inhaled BMD003(CFTR mRNA) in Chinese Adult Patients With Cystic Fibrosis

NCT06963008 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis (CF)
Gene Therapy

Interventions

DRUG: inhaled BMD003(CFTR mRNA)

Sponsor

Peking Union Medical College Hospital